![Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
30 October 2023
Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program
Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry...